Serviço de Cardiologia, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Serviço de Cardiologia, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Rev Port Cardiol. 2024 Nov;43(11):587-596. doi: 10.1016/j.repc.2024.02.008. Epub 2024 May 1.
Atrial fibrillation (AF) and heart failure (HF) often coexist. AF catheter ablation improves left ventricular ejection fraction (LVEF), but its impact varies between patients. We aimed to identify predictors of LVEF improvement in HF patients with impaired LVEF undergoing AF ablation.
We conducted a retrospective single-center study in HF patients with LVEF <50% undergoing AF catheter ablation between May 2016 and May 2022. The primary endpoint was the LVEF recovery rate ('responders'). Secondary endpoints were one-year safety and effectiveness. We also aimed to validate a prediction model for LVEF recovery.
The study included 100 patients (79% male, median age 60 years, 70% with probable tachycardia-induced cardiomyopathy [TIC], mean LVEF 37%, 29% with paroxysmal AF). After a median follow-up of 12 months after catheter ablation, LVEF improved significantly (36±10% vs. 53±10%, p<0.001), with an 82% responder rate. A suspected diagnosis of TIC (OR 4.916 [95% CI 1.166-20.732], p=0.030), shorter QRS duration (OR 0.969 [95% CI 0.945-0.994], p=0.015), and smaller left ventricle (OR 0.893 [95% CI 0.799-0.999], p=0.049) were independently associated with LVEF improvement. Freedom from any documented atrial arrhythmia was 86% (64% under antiarrhythmic drugs), and the rate of adverse events was 2%. The prediction model had a good discriminative performance (AUC 0.814 [95% CI 0.681-0.947]).
In AF patients with HF and impaired LVEF, suspected TIC, shorter QRS duration, and smaller LV diameter were associated with LVEF recovery following AF catheter ablation.
心房颤动(AF)和心力衰竭(HF)常同时存在。AF 导管消融可改善左心室射血分数(LVEF),但在不同患者中的效果不同。我们旨在确定接受 AF 导管消融的 LVEF 降低的 HF 患者中,预测 LVEF 改善的因素。
我们进行了一项回顾性单中心研究,纳入了 2016 年 5 月至 2022 年 5 月期间接受 AF 导管消融的 LVEF<50%的 HF 患者。主要终点是 LVEF 恢复率(“应答者”)。次要终点是一年的安全性和有效性。我们还旨在验证 LVEF 恢复的预测模型。
研究纳入了 100 例患者(79%为男性,中位年龄 60 岁,70%为可能的心动过速性心肌病[TIC],平均 LVEF 为 37%,29%为阵发性 AF)。在导管消融后中位随访 12 个月后,LVEF 显著改善(36±10% vs. 53±10%,p<0.001),应答率为 82%。疑似 TIC 诊断(OR 4.916 [95%CI 1.166-20.732],p=0.030)、较短的 QRS 持续时间(OR 0.969 [95%CI 0.945-0.994],p=0.015)和较小的左心室(OR 0.893 [95%CI 0.799-0.999],p=0.049)与 LVEF 改善独立相关。无任何记录的房性心律失常的比例为 86%(64%在使用抗心律失常药物),不良事件发生率为 2%。预测模型具有良好的判别性能(AUC 0.814 [95%CI 0.681-0.947])。
在 LVEF 降低的 HF 合并 AF 患者中,疑似 TIC、较短的 QRS 持续时间和较小的 LV 直径与 AF 导管消融后的 LVEF 恢复相关。